Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tong-Yuan Xue

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Future Oncology (London, England)|October 11, 2013
Novel oncoprotein EPS8: a new target for anticancer therapyYu-Hua Li, Tong-Yuan Xue, Ying-Zhi He, et al.
Clinical Laboratory|July 20, 2013
KIR2DL1-HLA signaling pathway: notable inhibition in the cytotoxicity of allo-NK cell against KG1A cellTong-Yuan Xue, Ying-Zhi He, Jia-Jia Zhang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|October 11, 2013
Novel oncoprotein EPS8: a new target for anticancer therapyYu-Hua Li, Tong-Yuan Xue, Ying-Zhi He, et al.
Clinical Laboratory|July 20, 2013
KIR2DL1-HLA signaling pathway: notable inhibition in the cytotoxicity of allo-NK cell against KG1A cellTong-Yuan Xue, Ying-Zhi He, Jia-Jia Zhang, et al.
Pageof 1